I think this is our last meeting on pharma until we get the budget officer's report back. I have a procedural motion:
That the analysts be directed to use the time period, as required, from today until Parliament resumes sitting in the fall, to complete a summary of evidence and testimony received so far in relation to the study of the development of a national pharmacare program, with a weighting to using peer-reviewed scientific evidence.
I put that forward as a motion so they can get started. We don't want to start cold in the fall when we get the parliamentary budget officer's report.